Alivus Life Sciences Limited has submitted a regulatory disclosure to the BSE Ltd. and the National Stock Exchange of India Ltd. The purpose of the filing is to intimate the exchanges of a scheduled meeting with an analyst/institutional investor, as required by SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
The disclosure is made specifically pursuant to Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR Regulations.
Meeting Details
A one-on-one meeting has been scheduled with the following details:
| Detail | Information |
| Date | June 16, 2026 |
| Attendee | Aditya Birla SunLife MF |
| Mode | In-Person |
| Place | Mumbai |
| Type | One on One |
The company has included a note that the provided schedule and mode of the meeting are subject to change due to any unforeseen exigencies on the part of the Investor, Analyst, or the Company itself.
The letter is signed by Rudalf Joseph Corriea, who holds the designation of Company Secretary & Compliance Officer. The document includes the company's contact information and details of its corporate and registered offices.